id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-274150-ukdha3ap	Choi, Jun Yong	Convalescent Plasma Therapy for Coronavirus Disease 2019	2020-09-03		.txt	text/plain	3163	169	42	Given its rapid acquisition, convalescent plasma therapy has been considered as an emergency intervention in several pandemics, including the Spanish flu, severe acute respiratory syndrome coronavirus (SARS-CoV-1), and West Nile virus, and more recently, Ebola virus [7] [8] [9] . Although large-scale randomized controlled trials have not yet been performed, and most studies did not evaluate neutralizing activities of used convalescent plasma, previous experiences on convalescent plasma therapy for the treatment of emerging infectious diseases provide us with important historical precedents that this intervention might be useful for confronting the COVID-19 epidemics. To evaluate the efficacy and adverse effects of convalescent plasma therapy for patients with COVID19 , an open-label, multicenter, randomized clinical trial was performed in seven medical centers in Wuhan, China. Some patients who recover from viral diseases may not have high titers of neutralizing antibodies, which are crucial for the effectiveness of convalescent plasma therapy [13, 14] .	./cache/cord-274150-ukdha3ap.txt	./txt/cord-274150-ukdha3ap.txt